Sponsor Experience Implementing Decentralised Clinical Trial (DCT) Elements: DCT Implementation Survey Results & Lessons Learned

About this session

Session: EVOLVING DCT APPROACHES: INNOVATION IN TRIAL DESIGN AND OPERATIONS

To understand the current state and future direction of decentralized clinical trials post-COVID-19, a survey was conducted across 14 sponsor companies to assess implementation experiences, success factors, and challenges in global clinical trials. Based on the survey learnings, this presentation will provide a greater understanding of innovative modern solutions that could help support more effective patient engagement and choice; A deeper understanding of best practices and barriers experienced when implementing DCT elements as part of global trials; A broad perspective of learnings related to DCT elements, across various stakeholders, that can be used to inform the ways of working for the industry and regulators; and access to available tools to support the acceleration of patient-centric modern approaches in clinical development.

Speaker

• JL

  Joachim Lovin

  DCT Specialist · Novo Nordisk A/S

  Speaker